Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Garuda Indonesia (Persero) Tbk. (GIAA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)

Garuda Indonesia (Persero) Tbk.Trading
Brigit Biofarmaka Teknologi Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Garuda Indonesia (Persero) Tbk. dan Brigit Biofarmaka Teknologi Tbk.: Garuda Indonesia (Persero) Tbk. diperdagangkan di Rp53 (kapitalisasi pasar 21,17 T, volume 24 jam 30,41 jt), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Garuda Indonesia (Persero) Tbk. jauh lebih besar — sekitar 126,5× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Garuda Indonesia (Persero) Tbk. lebih aktif diperdagangkan (30,41 jt vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.

GIAAOBAT
Kapitalisasi Pasar
21,17 T167,37 M
Volume
30,41 jt71 rb
Lot
304,11 rb710
Perputaran
1,59 M17,51 jt
Harga Rata-rata
52,22246,63
Nilai Transaksi
1,59 M17,51 jt
Harga Ekuilibrium Indikatif
53246
Volume Ekuilibrium Indikatif
5271

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

GIAA
Lihat detail
OBAT
Lihat detail

Tentang Garuda Indonesia (Persero) Tbk.

The Company is a state-owned airline of the republic of Indonesia and commercial air transportation service provider for passenger, cargo, and other services related to air transportation in Indonesia. The Company also provides services related aviation services, including repairs, maintenance and overhaul (MRO), aircraft, ground services, air tickets reservation and provision, and in fight catering, as well as travel services, tourism and hospitality.The Company was established on March 31, 1950 with the name of Garuda Indonesian Airways NV domiciled in Central Jakarta. In accordance with government regulations, in 1975 the company changed its form a Limited Liability Company (Persero) PT Garuda Indonesian Airways.

Selengkapnya di halaman GIAA

Tentang Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Selengkapnya di halaman OBAT